Terlipressin

규격

14636-12-5CAS 번호

238-680-8EC 번호

(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonylIUPAC 명칭

C52H74N16O15S2화학식

1227.4 g/mol분자량

Terlipressin; 14636-12-5; glypressin; glycylpressin; Terlipressine; Terlipressina; Terlipressinum; N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin; DTXSID7048952; Terlipresina; Variquel; (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide; glipressin; DTXCID0028878; 7Z5X49W53P; Gly Gly Gly 8 Lys vasopressin; terlypressin; triglycylvasopressin; TGLVP; triglycyl lysine vasopressin; vasopressin, tri-Gly-8-Lys-; Gly-Gly-Gly-8-Lys-vasopressin; (2S)-1-((4R,7S,10S,13S,16S,19R)-19-((2-((2-((2-aminoacetyl)amino)acetyl)amino)acetyl)amino)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-((4-hydroxyphenyl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)-N-((2S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide; (2S)-6-amino-2-(((2S)-1-(((4R,7S,10S,13S,16S,19R)-19-(2-(2-(2-aminoacetamido)acetamido)acetamido)-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-((4-hydroxyphenyl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl)carbonyl)pyrrolidin-2-yl)formamido)-N-(carbamoylmethyl)hexanamide; (2S)-6-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{2-[2-(2-aminoacetamido)acetamido]acetamido}-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide; RefChem:57981; tri-Gly-8-Lys-Vasopressin; N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin; H01BA04; N-(N-(N-glycylglycyl)glycyl)-L-lysinevasopressin; GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE); 238-680-8; Terlipressine [INN-French]; Terlipressinum [INN-Latin]; Terlipressina [INN-Spanish]; NCGC00185754-01; CHEMBL4088899; C52H74N16O15S2; EINECS 238-680-8; Terlipressin?; UNII-7Z5X49W53P; Terlipressin [USAN:INN:BAN]; Terlipressin CRS; BENFXAYNYRLAIU-QSVFAHTRSA-N; Lucassin (TN); HS-2028; Terlipressin (USAN/INN); SCHEMBL22699; orb1707801; CHEMBL2135460; GTPL11241; WZG0204; CHEBI:135905; EX-A3116; Tox21_113374; BDBM50248199; AKOS015994637; CCG-270662; CS-5769; DB02638; Terlipressin for NMR identification CRS; DA-58411; glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide; HY-12554; CAS-14636-12-5; NS00024791; C72780; D06672; Q324147; BRD-K73451719-001-01-2; (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-5-amino-1-[(2-amino-2-oxo-ethyl)carbamoyl]pentyl]pyrrolidine-2-carboxamide; (2S)-1-{(4R,7S,10S,13S,16S,19R)-19-{2-[2-(2-Aminoacetamido)acetamido]acetamido}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}-N-{(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide; (S)-N-((S)-6-Amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-19-(2-(2-(2-aminoacetamido)acetamido)acetamido)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide동의어